Infomail Archive, 2005

Infomail 2005 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Subscribe to the AHRP infomail list Dec 16: Drugs, Devices & Doctors – NYT Paul Krugman Dec 11: Scientific Fraud & Corruption on Both sides of Atlantic: Merck / Proctor & Gamble Dec 11: Gov Accountability…

FDA sends contradictory message re: addictive drugs for children – NIMH admits cognitive therapy as good as SSRIs

FDA sends contradictory message re: addictive drugs prescribed for children – NIMH admits cognitive therapy as good as SSRIs Fri, 27 May 2005 Two government health care agencies sent conflicting mixed messages about th euse of psychotropic drugs for children: The National Instiute of Mental Health issued an announcement acknowledging…

How to Quit the Cure–Antidepressant Withdrawal – NewsWeek

How to Quit the Cure–Antidepressant Withdrawal – NewsWeek Wed Aug 3, 2005 The current issue of NEWSWEEK lets readers in on the dirty little secret about the prescribed antidepressants of the SSRI variety. Although psychiatrists shudder at calling a spade a spade, these prescribed drugs are physically addictive–as is evident…

Dubious Drug Therapy – Keith Koeller / Bread and Shelter, Yes. Psychiatrists, No – Sally Satel

Dubious Drug Therapy – Keith Koeller / Bread and Shelter, Yes. Psychiatrists, No – Sally Satel Wed, 30 Mar 2005 Two OpEd columns deserve special attention because they provide insight and evidence of the harm done by current psychiatric / psychological practices. Sally Satel, MD is a psychiatrist and resident…

Former FDA Commissioner says FDA lost public trust

Former FDA Commissioner says FDA lost public trust Mon, 17 Oct 2005 The FDA’s failure to ensure drugs are properly tested in trials designed to detect serious adverse effects,  and the agency’s failure to require follow-up post-marketing studies to be reasonably secure in the knowledge that no lethal drugs are unleashed on the public has…

Prescriptions for antidepressant declined 10%

Prescriptions for antidepressant declined 10% Thu, 13 May 2004 The controversy over the safety of antidepressant drugs is broadening. The Newark Star Ledger reports a drop in antidepressant prescriptions since the Feb 2 FDA advisory committee meeting. Disclosure of long concealed evidence about the severe adverse drug effects–as well as…

Advisory Committee tells FDA: strengthen warnings on SSRI drug labels now

Advisory Committee tells FDA: strengthen warnings on SSRI drug labels now Wed, 4 Feb 2004 On February 2, more than 60 families and children from all across America testified at a public FDA advisory committee hearing describing (in 2 minutes) how their children suffered drug-induced harm after being prescribed an…

FDA Forced Wyeth to REMOVE Suicide Warning from Effexor Label

FDA Forced Wyeth to REMOVE Suicide Warning from Effexor Label Wed, 8 Sep 2004 The Wall Street Journal reports that FDA officials forced Wyeth to remove the label warning stating: “In pediatric clinical trials, there were increased reports of hostility and, especially in Major Depressive Disorder, suicide-related adverse events such…

Ex-NIH Director Lifted conflict of interest rules, Now favors limits on Drug-Company Ties – LAT

Ex-NIH Director Lifted conflict of interest rules, Now favors limits on Drug-Company Ties – LAT Sun, 14 Mar 2004 Former Director of the National Institutes of Health, Harold Varmus, MD, appeared before a blue ribbon panel convened by his former agency, ostensibly to shed light on conflict of interest at…

Seroxat (known as Paxil in the USA) is the subject of a major BBC-TV documentary

Seroxat (known as Paxil in the USA) is the subject of a major BBC-TV documentary (Panorama), to be shown on Sunday, 13 October 2002. Sent Fri Oct 11, 2002 The manufacturer of the worldís best selling antidepressant, GlaxoSmithKline, has been ruled in breach of the pharmaceutical industry ís own code…